The AACU and the WOCN Society urge CMS to protect access to individualized catheter and ostomy supplies as competitive bidding begins in 2028.
Related to this article
Enfortumab vedotin-ejfv (Padcev) plus pembrolizumab (Keytruda) showed the strongest EFS, OS, and pCR associations among neoadjuvant MIBC strategies in a network meta-analysis, although perioperative design limits attribution.
Independent urology faces stagnant Medicare pay, rising costs, prior auth burden, and consolidation pressure, Celeste Kirschner, CAE, MHSA, says.
Advertisement
Advertisement
Trending on Urology Times
1
Armine K. Smith, MD, on addressing sexual health in modern bladder cancer care
2
FDA grants 510(k) clearance to SpaceOAR Flex Hydrogel for prostate radiotherapy
3
PSMA PET's Expanding Role in Prostate Cancer Imaging
4
One year of Inlexzo: Evolving care in BCG-unresponsive NMIBC
5